Professor Abhilasha Karkey
Contact information
Podcast interview
Infectious diseases in Nepal

The primary goal of OUCRU-Nepal is improving public health in Nepal and South Asia, focusing on typhoid, antimicrobial resistance, and dengue increase linked with climate change. Over the recent years, the TCV typhoid vaccine trial emphasized the importance of regional collaboration and working with policymakers. OUCRU-Nepal has built strong hospital and community relationships, boosting global visibility and collaborations.
Abhilasha Karkey
Associate Professor
- Medical Microbiologist
 - Director of Oxford University Clinical Research Unit-Nepal
 
OUCRU Nepal
Abhilasha Karkey is a medical microbiologist at the Oxford University Clinical Research Unit in Kathmandu, Nepal, which is associated with the Patan Academy of Health Sciences within Patan Hospital. She is involved with several infectious disease research projects including enteric fever, central nervous system infections, hepatitis E, tuberculosis, and antibiotic resistance. Her main research includes looking at nosocomial infections and antibiotic resistance patterns within the population, as well as molecular epidemiology of enteric fever within the study population in Kathmandu.
Recent publications
- 
                            
    
        
            
                Research Electronic Data Capture (REDCap) for Population-Based Data Collection in Low- and Middle-Income Countries: Opportunities, Challenges, and Solutions.
Le HT. et al, (2025), J Med Internet Res, 27
 - 
                            
    
        
            
                Life from death: ethical implications of uterus transplantation from deceased donors in global health
Suwalowska H. et al, (2025), BMJ Global Health, 10, e018216 - e018216
 - 
                            
    
        
            
                Identifying context-specific determinants to inform improvement of antimicrobial stewardship implementation in healthcare facilities in Asia: results from a scoping review and web-based survey among local experts.
Limato R. et al, (2025), BMJ open quality, 14
 - 
                            
    
        
            
                The <i>Salmonella</i> Paratyphi A O-Antigen Glycoconjugate Vaccine Is Able to Induce Antibodies with Bactericidal Activity Against a Panel of Clinical Isolates.
Pinto M. et al, (2025), Vaccines, 13
 - 
                            
    
        
            
                Modelling Salmonella Typhi in high-density urban Blantyre neighbourhood, Malawi, using point pattern methods
Khaki JJ. et al, (2024), Scientific Reports, 14